I have built a strong academic and research career that integrates veterinary medicine, pharmacology, and cancer biology, with a focus on translational oncology. With over a decade of higher education teaching experience, including roles as Lecturer and Assistant Professor, I have taught diverse subjects such as pharmacology, toxicology, epidemiology, and public health, helping shape the next generation of professionals. My research achievements center on unraveling the complexity of drug resistance and oncogene regulation, especially c-MYC, in cancers such as triple-negative breast cancer and non-small-cell lung cancer. I contributed new insights by demonstrating indirect strategies to target MYC through regulators such as BRD4 and RRM2, as well as approaches that enhance MYC mRNA knockdown via asymmetric siRNA. I also investigated MYC-driven DNA repair mechanisms, including RAD51, PARP1, RRM2, and γ-H2AX, advancing the understanding of therapeutic vulnerabilities. With international research training, publications, and mentoring experience, I remain committed to developing innovative precision therapies and drug discovery that benefit human health.
Currently working as a postdoctoral researcher at Seoul National University, Research Institute of Pharmaceutical Sciences.